INDRAPRASTHA MEDICAL (India) Today

INDRAPRASTHA MEDICAL is trading at 82.35 as of the 26th of September 2021, a 5.78% increase since the beginning of the trading day. The stock's lowest day price was 77.15. Equity ratings for INDRAPRASTHA MEDICAL CORP are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of August 2021 and ending today, the 26th of September 2021. Click here to learn more.
Valuation
Check how we calculate scores

INDRAPRASTHA MEDICAL Stock Profile

Indraprastha Medical Corporation Limited provides hospital services in India. Indraprastha Medical Corporation Limited was incorporated in 1988 and is based in New Delhi, India. INDRAPRASTHA MEDICAL operates under Medical Care Facilities classification in India and is traded on Bombay Stock Exchange. It employs 3215 people. more on INDRAPRASTHA MEDICAL
INDRAPRASTHA MEDICAL is not yet fully synchronised with the market data
INDRAPRASTHA MEDICAL generates negative expected return over the last 90 days
INDRAPRASTHA MEDICAL is unlikely to experience financial distress in the next 2 years
About 58.0% of the company shares are held by company insiders
Legal NameINDRAPRASTHA MEDICAL CORP
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of INDRAPRASTHA MEDICAL's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) is traded on Bombay Stock Exchange in India and employs 3,215 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 7.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate INDRAPRASTHA MEDICAL's market, we take the total number of its shares issued and multiply it by INDRAPRASTHA MEDICAL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. INDRAPRASTHA MEDICAL operates under Healthcare sector and is part of Medical Care Facilities industry. The entity has 91.67 M outstanding shares. INDRAPRASTHA MEDICAL CORP has accumulated about 203.32 M in cash with 864.51 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.22.
Check INDRAPRASTHA MEDICAL Probability Of Bankruptcy

INDRAPRASTHA Stock Price Odds Analysis

What are INDRAPRASTHA MEDICAL's target price odds to finish over the current price? Based on a normal probability distribution, the odds of INDRAPRASTHA MEDICAL jumping above the current price in 90 days from now is about 62.82%. The INDRAPRASTHA MEDICAL CORP probability density function shows the probability of INDRAPRASTHA MEDICAL stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon INDRAPRASTHA MEDICAL CORP has a beta of -0.1923. This usually indicates as returns on benchmark increase, returns on holding INDRAPRASTHA MEDICAL are expected to decrease at a much lower rate. During the bear market, however, INDRAPRASTHA MEDICAL CORP is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. INDRAPRASTHA MEDICAL is significantly underperforming DOW.
 Odds Down 82.35HorizonTargetOdds Up 82.35 
36.99%90 days
 82.35 
62.82%
Based on a normal probability distribution, the odds of INDRAPRASTHA MEDICAL to move above the current price in 90 days from now is about 62.82 (This INDRAPRASTHA MEDICAL CORP probability density function shows the probability of INDRAPRASTHA Stock to fall within a particular range of prices over 90 days) .

INDRAPRASTHA MEDICAL Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. INDRAPRASTHA MEDICAL market risk premium is the additional return an investor will receive from holding INDRAPRASTHA MEDICAL long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in INDRAPRASTHA MEDICAL. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although INDRAPRASTHA MEDICAL's alpha and beta are two of the key measurements used to evaluate INDRAPRASTHA MEDICAL's performance over the market, the standard measures of volatility play an important role as well.

INDRAPRASTHA Stock Against Markets

Picking the right benchmark for INDRAPRASTHA MEDICAL stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in INDRAPRASTHA MEDICAL stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for INDRAPRASTHA MEDICAL is critical whether you are bullish or bearish towards INDRAPRASTHA MEDICAL CORP at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with INDRAPRASTHA MEDICAL stock to make a market-neutral strategy. Peer analysis of INDRAPRASTHA MEDICAL could also be used in its relative valuation, which is a method of valuing INDRAPRASTHA MEDICAL by comparing valuation metrics with similar companies.
Please see Risk vs Return Analysis. Note that the INDRAPRASTHA MEDICAL information on this page should be used as a complementary analysis to other INDRAPRASTHA MEDICAL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Other Tools for INDRAPRASTHA Stock

When running INDRAPRASTHA MEDICAL price analysis, check to measure INDRAPRASTHA MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INDRAPRASTHA MEDICAL is operating at the current time. Most of INDRAPRASTHA MEDICAL's value examination focuses on studying past and present price action to predict the probability of INDRAPRASTHA MEDICAL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move INDRAPRASTHA MEDICAL's price. Additionally, you may evaluate how the addition of INDRAPRASTHA MEDICAL to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go